Rani Therapeutics Holdings, Inc. (RANI) Volatility Skew
Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.
Rani Therapeutics Holdings, Inc. (RANI) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $68.6M, listed on NASDAQ, employing roughly 105 people, carrying a beta of 0.76 to the broader market. Rani Therapeutics Holdings, Inc. Led by Talat Imran, public since 2021-07-30.
Snapshot as of May 15, 2026.
- Spot Price
- $1.10
- ATM IV
- 203.0%
- IV Skew 25Δ
- 0.368
- IV Rank
- 42.7%
- IV Percentile
- 36.5%
- Term Structure Slope
- -0.053
As of May 15, 2026, Rani Therapeutics Holdings, Inc. (RANI) at-the-money implied volatility is 203.0%. IV rank is 42.7% (where 0% is the 52-week low and 100% is the 52-week high). IV percentile is 36.5%. The 25-delta skew is +0.368: calls carry premium over puts, indicating upside speculation or squeeze risk. High IV rank typically favors premium-selling strategies; low IV rank favors premium-buying.
RANI Strategy Selection at Current Volatility Levels
For Rani Therapeutics Holdings, Inc. options at 203.0% ATM IV, mid-range IV rank (42.7%) is the regime where directional conviction matters more than vol-regime positioning; strategy choice should follow the event calendar and the dealer-positioning view rather than IV rank alone. The 25-delta skew tilts to calls, so call-credit spreads or covered-call writes harvest more premium than put-credit spreads of the same width. Pair the vol-rank read with the dealer-gamma view and the upcoming-events calendar to confirm the strategy fits both the structural regime and the path-dependent risk. The variance risk premium - the persistent gap between implied and subsequently realized vol - is positive in equity markets on average; high IV rank typically reflects a stretch where the premium is wider than usual.
Learn how volatility skew is reported and how to read the data →
Frequently asked RANI volatility skew questions
- What is the current RANI ATM implied volatility?
- As of May 15, 2026, Rani Therapeutics Holdings, Inc. (RANI) at-the-money implied volatility is 203.0%. IV rank is 42.7% on a 0-100% scale anchored to the 1-year IV range. ATM IV is the volatility input that makes a Black-Scholes-equivalent model reproduce the listed at-the-money option prices.
- Is RANI IV high or low historically?
- IV is near its 1-year median, a regime where strategy choice depends on directional conviction and event calendar rather than vol regime.
- What does RANI volatility skew tell options traders?
- Volatility skew is the pattern by which IV varies across strikes for a given expiration. Rani Therapeutics Holdings, Inc. shows upside-skewed pricing: 25-delta calls trade richer than 25-delta puts, often reflecting upside speculation or squeeze risk. Skew matters for risk-defined strategy selection: when downside puts are rich, put-credit spreads capture more premium; when upside calls are rich, call-credit spreads or covered-call writes harvest more.